OFT to investigate heartburn drug competition
Household goods giant Reckitt Benckiser has been accused of abusing its dominant position in the supply of heartburn medicines to the NHS.
Subscriber only content
You must be a paid subscriber to Health Service Journal magazine to read this article and receive complete, unrestricted access to hsj.co.uk
HSJ Subscribers:
If you are a Health Service Journal subscriber please sign in with your email address and click submit:
Not a HSJ subscriber?
Choose one of these options:
Subscribe today for immediate access to hsj.co.uk and Health Service Journal magazine
Find out more about the benefits of a subscription to HSJ by clicking below, or view a sample issue here
